CTLA4 and glioblastoma: Our investigation has revealed a compelling positive link between the expression of POLD4 and the presence of immune checkpoint indicators (TIGIT, CD274, CTLA4, and PDCD1) in both GBM (Figure 8A) and LGG (Figure 8B).